Olympus Issues Voluntary Field Action to Remind Users of Warnings for Bronchoscopes Used with High-Frequency Therapy Equipment

CENTER VALLEY, Pa., Nov. 9, 2023 /PRNewswire/ — Olympus Corporation has announced a voluntary field corrective action to address complaints of endobronchial combustion occurring during therapeutic procedures involving use of high-frequency therapy equipment in an […]


Melinta Therapeutics and Venatorx Pharmaceuticals Announce Licensing Agreement to Commercialize Cefepime-Taniborbactam in the U.S.

PARSIPPANY, N.J. & MALVERN, Pa.–(BUSINESS WIRE)–Melinta Therapeutics LLC (“Melinta”) and Venatorx Pharmaceuticals, Inc. (“Venatorx”), today announced that they have entered into a License Agreement to facilitate a strategic partnership in the U.S. to commercialize cefepime-taniborbactam, […]

No Picture

Immunome Reports Third Quarter 2023 Financial Results

SEATTLE & EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today reported financial results for the third quarter ended September 30, 2023 and provided a […]